FMTCOCP
CRSP icon

Farmers & Merchants Trust Co of Chambersburg PA’s CRISPR Therapeutics CRSP Stock Holding History

Farmers & Merchants Trust Co of Chambersburg PA’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-500
Closed -$37K – 277
2020
Q2 		$37K Hold
500
– – 0.03% 167
2020
Q1 		$21K Buy
500
+80
+19% +$4.13K 0.02% 192
2019
Q4 		$26K Buy
+420
New +$22.9K 0.02% 208
2018
Q4 		– Sell
-225
Closed -$10K – 270
2018
Q3 		$10K Buy
+225
New +$11.8K 0.01% 227

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Farmers & Merchants Trust Co of Chambersburg PA's CRSP Position: Q3 2020 in Review

Farmers & Merchants Trust Co of Chambersburg PA sold out of CRISPR Therapeutics (CRSP) in Q3 2020, closing a stake of 500 shares — an estimated $37K sold.

Farmers & Merchants Trust Co of Chambersburg PA first reported a position in CRSP in Q3 2018 and held it in 4 quarters. The position peaked at $37K in Q2 2020. 310 funds tracked by Wall St. Rank hold CRSP as of Q3 2020.

  • Farmers & Merchants Trust Co of Chambersburg PA reported no remaining CRISPR Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Farmers & Merchants Trust Co of Chambersburg PA sold 500 CRISPR Therapeutics shares in Q3 2020, an estimated $37K.
  • Farmers & Merchants Trust Co of Chambersburg PA first reported a position in CRISPR Therapeutics in Q3 2018 and held it in 4 quarters.
  • Farmers & Merchants Trust Co of Chambersburg PA's CRISPR Therapeutics position peaked at $37K in Q2 2020.
  • 310 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2020.

Based on Farmers & Merchants Trust Co of Chambersburg PA's 13F filing for Q3 2020, filed 19 Oct 2020.